While this represents a higher per-treatment cost than oral supplements, the superior absorption and reduced frequency often make injections cost-competitive over time, particularly for those who dont absorb oral forms effectively
PMID: 30800297
Monitoring Requirements in Liver-Compromised Patients Baseline laboratory assessment should include a comprehensive metabolic panel (ALT, AST, alkaline phosphatase, total and direct bilirubin, albumin), complete blood count with platelets, and coagulation studies (INR/PT)
Keep a peptide log that records lot numbers, reconstitution dates, and stability observations so that results can be reproduced and anomalies traced back to a specific batch
For general supplementation, the differences between these forms are unlikely to be clinically meaningful for most people